{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:50:09Z","timestamp":1775505009790,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.clon.2026.104076","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:34:07Z","timestamp":1770424447000},"page":"104076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of Chemotherapy Efficacy in Primary Gastric Diffuse Large B-cell Lymphoma on a Point-based Scoring System: A Multicenter Study"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8938-0610","authenticated-orcid":false,"given":"S.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104076_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semcancer.2011.09.010","article-title":"Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes","volume":"21","author":"Smedby","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.clon.2026.104076_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000350051","article-title":"Gastrointestinal lymphoma: recent advances in diagnosis and treatment","volume":"87","author":"Nakamura","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.clon.2026.104076_bib3","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/cncr.11415","article-title":"Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends","volume":"97","author":"Nakamura","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2026.104076_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ejh.12467","article-title":"Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET\/CT metrics in diffuse large B-cell lymphoma","volume":"94","author":"Adams","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clon.2026.104076_bib5","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/blood-2008-02-137513","article-title":"Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma","volume":"112","author":"Kuo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clon.2026.104076_bib6","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1186\/s12885-021-08963-6","article-title":"Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: a retrospective analysis","volume":"21","author":"Fan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clon.2026.104076_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41416-018-0183-x","article-title":"Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission","volume":"119","author":"Hawkes","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2026.104076_bib8","first-page":"469","article-title":"Bone marrow disease detection with FDG-PET\/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study","volume":"55","author":"Pelosi","year":"2011","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.clon.2026.104076_bib9","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2013.0037","article-title":"Non-Hodgkin's lymphomas, version 1.2013","volume":"11","author":"Zelenetz","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clon.2026.104076_bib10","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104076_bib11","article-title":"Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET\/CT Parameters in Primary Gastric DLBCL","volume":"57","author":"Albano","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clon.2026.104076_bib12","doi-asserted-by":"crossref","first-page":"9757","DOI":"10.1007\/s00432-023-04862-4","article-title":"A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy","volume":"149","author":"Wang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.clon.2026.104076_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: The Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clon.2026.104076_bib14","first-page":"1563","article-title":"[Influence of Peripheral Blood Lymphocyte\/Monocyte ratio (LMR) and Its Ratio to Lactate Dehydrogenase on Prognosis of Patients with Diffuse Large B-Cell Lymphoma]","volume":"28","author":"Yang","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.clon.2026.104076_bib15","first-page":"15","article-title":"Evaluation of parameters with potential prognosis impact in patients with primary gastric diffuse large B-cell lymphoma (PG-DLBCL)","volume":"55","author":"Rotaru","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.clon.2026.104076_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1186\/s12879-023-08671-5","article-title":"Profiling risk factors for separation of infection complications in patients with gastrointestinal and nodal diffuse large B-cell lymphoma","volume":"23","author":"Xue","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clon.2026.104076_bib17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/00365521.2016.1177854","article-title":"Role of follow-up endoscopic examination in treatment response assessment for patients with gastric diffuse large B cell lymphoma","volume":"51","author":"Yoon","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clon.2026.104076_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.23688","article-title":"Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma","volume":"89","author":"El-Galaly","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clon.2026.104076_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.12370","article-title":"Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology","volume":"10","author":"Lee","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.clon.2026.104076_bib20","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.21037\/qims-23-251","article-title":"Predicting diffuse large B-cell lymphoma outcomes with lesion-to-liver maximum standardized uptake value for interim-treatment and end-of-treatment positron emission tomography-computed tomography","volume":"13","author":"Wang","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.clon.2026.104076_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/nbm.2933","article-title":"Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study","volume":"26","author":"Wu","year":"2013","journal-title":"NMR Biomed"},{"key":"10.1016\/j.clon.2026.104076_bib22","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","article-title":"Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma","volume":"32","author":"Thompson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104076_bib23","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2011.35.0736","article-title":"Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants","volume":"29","author":"Trotman","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104076_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12885-020-6578-0","article-title":"Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer","volume":"20","author":"Ni-Jia-Ti","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clon.2026.104076_bib25","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1002\/cam4.2323","article-title":"Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX\u00ae recurrence score <26","volume":"8","author":"Turner","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.clon.2026.104076_bib26","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2147\/CMAR.S171129","article-title":"Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy","volume":"10","author":"Lai","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clon.2026.104076_bib27","article-title":"Establishment of a risk scoring system for predicting locoregional recurrence in T1 to T2 node-negative breast cancer patients treated with mastectomy: Implications for postoperative radiotherapy","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clon.2026.104076_bib28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/tbj.13115","article-title":"A new risk stratification score for the management of ultrasound-detected B3 breast lesions","volume":"24","author":"Giuliani","year":"2018","journal-title":"Breast J"},{"key":"10.1016\/j.clon.2026.104076_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.suronc.2018.02.003","article-title":"Risk scoring system for predicting axillary response after neoadjuvant chemotherapy in initially node-positive women with breast cancer","volume":"27","author":"Ouldamer","year":"2018","journal-title":"Surg Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:02:31Z","timestamp":1775502151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"alternative-id":["S0936655526000476"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104076","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Chemotherapy Efficacy in Primary Gastric Diffuse Large B-cell Lymphoma on a Point-based Scoring System: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104076"}}